A. Thomas

发表

Vascular Endothelial Growth Factor (VEGF) Inhibition by Small Molecules

W. Steward, A. Thomas, S. I. Ahmed, 2004, Journal of chemotherapy.

Chemotherapy for upper gastrointestinal tumours

K. O'Byrne, W. Steward, A. Thomas, 2000, Postgraduate medical journal.

The Early Use of PET-CT Alters the Management of Patients with Esophageal Cancer

R. N. Williams, C. Sutton, S. Ubhi, 2009, Journal of Gastrointestinal Surgery.

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.

J. Roh, J. Zalcberg, G. Folprecht, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials.

J. Wood, J. Pinheiro, J. Drevs, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer.

P. Calder, M. Metcalfe, A. Dennison, 2017, Clinical nutrition.

Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.

S. Parsons, S. Madhusudan, D. Bowrey, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

528PAFLIBERCEPT + FOLFIRI FOR TREATMENT OF METASTATIC COLORECTAL CANCER AFTER OXALIPLATIN FAILURE: 4TH INTERIM SAFETY DATA FROM THE GLOBAL AFLIBERCEPT SAFETY AND QUALITY-OF-LIFE PROGRAM (ASQOP/AFEQT STUDIES).

V. Heinemann, J. Taieb, A. Sobrero, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging

M. Horsfield, B. Morgan, W. Steward, 2006, British Journal of Cancer.

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

K. O'Byrne, Ricky A. Sharma, W. Steward, 2002, British Journal of Cancer.

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study.

R A Sharma, K Jeyapalan, A L Thomas, 2000, European journal of cancer.

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer.

U. Vanhoefer, B. Wiedenmann, T. Trarbach, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of LDE225 in advanced solid tumors: Updated analysis of safety, preliminary efficacy, and pharmacokinetic-pharmacodynamic correlation.

R. Dummer, H. Tawbi, J. Dey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer.

P. Calder, A. Dennison, D. Bowrey, 2017, Clinical nutrition.

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

A. B. Benson, J. Ajani, A. Benson, 2008, Cancer Chemotherapy and Pharmacology.

Gemcitabine--a major advance?

W. Steward, A. Thomas, 1998, Annals of Oncology.

A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours.

G. Attard, W. Steward, A. Greystoke, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.